BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1333 related articles for article (PubMed ID: 15791354)

  • 1. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease progression in the oldest old compared to younger elderly patient: data from the REAL.FR study.
    Nourhashémi F; Gillette-Guyonnet S; Rolland Y; Cantet C; Hein C; Vellas B
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):149-55. PubMed ID: 18613005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).
    Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B;
    J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of rate of loss of autonomy in Alzheimer's disease patients. A prospective study of the REAL.FR Cohort.
    Lechowski L; De Stampa M; Tortrat D; Teillet L; Benoit M; Robert PH; Vellas B;
    J Nutr Health Aging; 2005; 9(2):100-4. PubMed ID: 15791353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.
    Nourhashemi F; Amouyal-Barkate K; Gillette-Guyonnet S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):117-20. PubMed ID: 15791356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
    Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
    J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort).
    Nourhashémi F; Ousset PJ; Gillette-Guyonnet S; Cantet C; Andrieu S; Vellas B;
    Int J Geriatr Psychiatry; 2008 May; 23(5):460-5. PubMed ID: 17894422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between arterial pressure and cognitive functions. Data for the French Network on Alzheimer's disease (REAL.FR)].
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS
    Rev Med Interne; 2003 Oct; 24 Suppl 3():292s-300s. PubMed ID: 14710447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.